Analgesics - Turkey

  • Turkey
  • In Turkey, the revenue generated in the Analgesics market in 2024 amounts to US$255.30m.
  • It is projected that the market will experience an annual growth rate of 5.42% from 2024 to 2029 (CAGR 2024-2029).
  • When compared globally, the in the United States generates the highest revenue in the Analgesics market, amounting to US$7,243.00m in 2024.
  • In terms of per person revenues, in Turkey generates US$2.96 per individual in 2024.
  • Turkey's analgesics market is experiencing a surge in demand for traditional herbal remedies due to growing interest in natural and alternative medicine.

Key regions: Canada, United States, United Kingdom, Australia, Germany

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Analgesics market in Turkey has been experiencing significant growth in recent years, driven by various factors such as changing customer preferences, emerging trends in the market, local special circumstances, and underlying macroeconomic factors.Customer preferences in the Analgesics market have shifted towards a preference for over-the-counter (OTC) products. This can be attributed to the convenience and accessibility of OTC analgesics, as well as the increasing awareness among consumers about self-medication. Additionally, there is a growing demand for analgesic products that provide fast and effective relief from pain, as consumers seek immediate relief from their symptoms.In terms of trends, there has been a rise in the demand for natural and herbal analgesics in the Turkish market. This can be attributed to the increasing consumer preference for natural and organic products, as well as the perception that natural remedies have fewer side effects compared to synthetic drugs. Manufacturers have responded to this trend by introducing a wide range of natural and herbal analgesic products to cater to the growing demand.Another trend in the market is the increasing use of online platforms for purchasing analgesic products. With the rise of e-commerce in Turkey, consumers are increasingly turning to online platforms to conveniently purchase their analgesics. This trend has been further accelerated by the COVID-19 pandemic, as consumers have become more reliant on online shopping for their healthcare needs.Local special circumstances also play a role in the development of the Analgesics market in Turkey. The country has a large and growing aging population, which is driving the demand for analgesic products. As individuals age, they are more likely to experience chronic pain and require regular pain management. This has created a significant market opportunity for analgesic manufacturers to cater to the needs of this demographic.Underlying macroeconomic factors such as increasing disposable income and improved healthcare infrastructure are also contributing to the growth of the Analgesics market in Turkey. As disposable income levels rise, consumers have more spending power to purchase analgesic products. Additionally, the improved healthcare infrastructure in the country has led to increased access to healthcare services, including pain management, which has further fueled the demand for analgesics.In conclusion, the Analgesics market in Turkey is developing in response to changing customer preferences, emerging trends in the market, local special circumstances, and underlying macroeconomic factors. The shift towards OTC products, the demand for natural and herbal analgesics, the rise of online platforms for purchasing analgesics, the aging population, increasing disposable income, and improved healthcare infrastructure are all contributing to the growth of the market.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Key Players
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)